Summary
Kathleen Dungan, MD, MPH, discusses emerging and future pharmacotherapies for patients with type 2 diabetes. Dr. Dungan describes currently available GLP-1 agonists and SGLT-2 inhibitor medications, highlighting Medicaid coverage for newer diabetes pharmacotherapies.
